Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 21 of the 25 references it cites were found in a registry or an index; 22 of the 28 sources its claims cite were checked for support.

Human Herpesvirus 6—A Rare Aetiologic Agent for CNS Infections in Immunocompetent Individuals or an Underestimation?

Open access
Ganea, Oana Alexandra, Tilișcan, Cătălin, Streinu-Cercel, Anca, Pițigoi, Daniela, Drăgănescu, Anca Cristina, Lazar, Mihai, Mihai, Nicoleta, Florea, Dragoș, Aramă, Sorin Ștefan, Aramă, Victoria · 2024 · Journal of Clinical Medicine

Abstract

Background: Human herpesvirus 6 (HHV-6) is considered a ubiquitous virus, with many countries reporting a seroprevalence of more than 80–90% among the general population. However, this virus is unique among herpesviruses in its ability to integrate into the genetic material of the host’s cells. Thus, there are three ways by which HHV-6 can cause an active infection–primary infection, reactivation of a latent acquired infection, or activation of iciHHV-6 (inherited chromosomally integrated HHV-6). Whole blood quantitative polymerase chain reaction (qPCR) is very useful in distinguishing between iciHHV-6 and primary infection/reactivation. Our aim is to assess the role of HHV-6 in the aetiology of central nervous system (CNS) infections in adults and children, to describe all HHV-6-positive cases in an attempt to determine the susceptible population and to identify potential risk factors that can be linked to HHV-6 meningoencephalitis. Methods: We performed a retrospective study involving patients that were admitted to Prof. Dr. Matei Bals National Institute of Infectious Diseases, Bucharest, Romania, with a diagnosis of meningitis or encephalitis. We only selected the clinical records of patients that had a multiplex PCR Biofire® FilmArray® meningitis/encephalitis panel. Results: We report a 5% HHV-6 positivity in the cerebrospinal fluid (CSF) of patients with CNS infections tested with a commercial multiplex PCR M/E (meningitis/encephalitis) panel. Additionally, 2% to 4% of the total study population (n = 100) had active HHV-6 infections, which denotes 40 to 80% of the HHV-6-positive samples. We did not observe any statistically significant correlation between HHV-6 positivity in the CSF and variables such as age, sex, or comorbidities, including obesity, diabetes, hypertension, immunosuppression, or oncologic disease. Therefore, no risk factors could be linked with HHV-6 positivity in the CSF. Conclusions: although multiplex qualitative PCR is highly useful for providing rapid results and identifying nearly every pathogen that can cause meningitis/encephalitis, we have to be aware of this type of test’s limitations. All patients with HHV-6 detectable in their CSF via a multiplex PCR test should also undergo qPCR testing from both CSF and blood to prevent over-diagnosing HHV-6 CNS infections, to avoid unnecessary antiviral treatments, and ensure the accurate identification of the true diagnosis.

Overview

CoChat Summary

TL;DR

This retrospective single-center study of 100 meningitis/encephalitis patients found HHV-6 DNA in CSF in 5% of cases, but only 2%–4% were judged to represent active HHV-6 CNS infection after considering blood/CSF qPCR and clinical context. The authors argue that multiplex qualitative PCR alone can overcall HHV-6 CNS disease and that paired CSF and blood qPCR is needed to distinguish active infection from iciHHV-6 or reactivation.

Key findings

  • Among 100 patients tested with a multiplex CSF panel, 5/100 (5%) had HHV-6 detectable in CSF; 2/19 pediatric patients (10%) and 3/81 adults (2.43% of adults) were HHV-6-positive.
  • The study reports 2%–4% of the total sample (2/100 to 4/100) had active HHV-6 infection, corresponding to 40%–80% of HHV-6-positive CSF samples.
  • No statistically significant correlation was found between HHV-6 CSF positivity and age, sex, obesity, diabetes, hypertension, immunosuppression, or oncologic disease.
  • Of the 5 HHV-6-positive cases, 2 pediatric cases were interpreted as primary infection, 1 adult case as HHV-6 reactivation with Listeria monocytogenes meningitis, 1 as likely bacterial nosocomial meningitis with uncertain HHV-6 role, and 1 as possible HHV-6-triggered Rasmussen encephalitis in a patient with HIV but normal CD4 count and undetectable HIV RNA.

Methods

  • Retrospective study at Prof. Dr. Matei Bals National Institute of Infectious Diseases (Bucharest, Romania), including patients admitted with meningitis or encephalitis between 1 January 2022 and 30 May 2023.
  • Included only patients who had CSF multiplex PCR (Biofire FilmArray meningitis/encephalitis panel); after exclusions, the analyzed sample was 100 patients.
  • Collected clinical records data on demographics, symptoms, comorbidities, labs, CSF parameters, cultures, treatment, and performed qualitative multiplex PCR, with qPCR from blood and/or CSF in selected cases; associations were tested with chi-square/non-parametric analyses in SPSS v26.

Limitations

  • The authors state the study was retrospective, which prevented qPCR testing on all HHV-6-positive CSF cases and left uncertainty in at least one case about iciHHV-6 versus reactivation.
  • The sample was small and single-center, which the authors note may help explain differences from prior studies.
  • Evident from the text: conclusions about “active HHV-6” rest on only 2 cases with paired qPCR from blood and CSF, so case classification is limited by incomplete molecular confirmation.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/jcm13164660

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Study population description. * M/E = meningitis/encephalitis/meningoencephalitis.
Figure 1 Study population description. * M/E = meningitis/encephalitis/meningoencephalitis.CC BY · PubMed Central
Figure 2 Aetiologic agents identified in our cohort.
Figure 2 Aetiologic agents identified in our cohort.CC BY · PubMed Central

Verification

Claims the paper makes

7 Valid · 5 Not valid · 3 Not checked · 50 Own results and interpretations

29 more claims · 1 with their cited sources checked

Create a free account to see all 65 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 25
  • Probably not a substantial claim. 9

Create a free account to see these claims.

Citations

Cites

Show all 25 references

Cited by

See all 7

Metadata

Authors
Ganea, O. A., Tilișcan, C., Streinu-Cercel, A., Pițigoi, D., Drăgănescu, A. C., Lazar, M., Mihai, N., Florea, D., Aramă, S. Ș., & Aramă, V.
Affiliations
  • Carol Davila University of Medicine and Pharmacy (RO)
  • Faculty of General Medicine, Department of Infectious Diseases, “Carol Davila” University of Medicine and Pharmacy, Dionisie Lupu Street No. 37, 010458 Bucharest, Romania
  • “Matei Bals” National Institute of Infectious Diseases, Dr. Calistrat Grozovici Street No. 1, 021105 Bucharest, Romania
Venue
Journal of Clinical Medicine
Publisher
MDPI AG
Published
2024-08-08
Volume
13
Issue
16
Pages
4660
ISSN
2077-0383 (ISSN-L)
OpenAlex
W4401416646
Cited by
7
References
25
Citations by year
2026: 6 · 2025: 1
FWCI
1.97
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
University of Medicine and Pharmacy Carol Davila
Topics
  • Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
  • Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
  • Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
Keywords
human herpesvirus 6, central nervous system infection, meningitis, encephalitis, immunocompetent patient, HHV-6 reactivation, BioFire FilmArray, cerebrospinal fluid, risk factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human Herpesvirus 6—A Rare Aetiologic Agent for CNS Infections in Immunocompetent Individuals or an Underestimation? https://app.cochat.ai/papers/10.3390/jcm13164660
The paper
Ganea, O. A., Tilișcan, C., Streinu-Cercel, A., Pițigoi, D., Drăgănescu, A. C., Lazar, M., Mihai, N., Florea, D., Aramă, S. Ș., & Aramă, V. (2024). Human Herpesvirus 6—A Rare Aetiologic Agent for CNS Infections in Immunocompetent Individuals or an Underestimation? Journal of Clinical Medicine. https://doi.org/10.3390/jcm13164660

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.